A novel secreted glycoprotein that regulates bone resorption has been
identified. The protein, termed Osteoprotegerin (OPG), is a novel memb
er of the TNF receptor superfamily. In vivo, hepatic expression of OPG
in transgenic mice results in a profound yet nonlethal osteopetrosis,
coincident with a decrease in later stages of osteoclast differentiat
ion. These same effects are observed upon administration of recombinan
t OPG into normal mice. In vitro, osteoclast differentiation from prec
ursor cells is blocked in a dose-dependent manner by recombinant OPG.
Furthermore, OPG blocks ovariectomy-associated bone loss in rats. Thes
e data show that OPG can act as a soluble factor in the regulation of
bone mass and imply a utility for OPG in the treatment of osteoporosis
associated with increased osteoclast activity.